Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
1-Deoxynojirimycin
Cat. No.:
0225LY-0716
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, HPLC, and LC-MS.
Size:
Add to basket
Product Overview
Description:
1-Deoxynojirimycin is a strong inhibitor of alpha-glucosidase that helps lower blood glucose levels after meals, potentially serving as a preventative measure for diabetes.
Synonym:
Duvoglustat; Moranoline;moranolin; 19130-96-2; (2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol; Moranolin; 1 Deoxynojirimycin; 1,5-Deoxy-1,5-imino-D-mannitol; D-1-deoxynojirimycin; 1,5-Dideoxy-1,5-imino-D-glucitol
CAS No.:
19130-96-2
Compound CID:
29435
Formula:
C6H13NO4
Formula Weight:
163.17
Specification
Relative Density:
1.456 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
1-Deoxynojirimycin can be used in biochemical assays to investigate the role of iminosugars in treating metabolic disorders and lysosomal storage diseases.
Library Information
Target:
PI3K; α-Glucosidase
Receptor:
PI3K; α-Glucosidase
Pathways:
PI3K/Akt/mTOR signaling; Metabolism
Plate Number:
AOCL-10
Plate Location:
c3
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
17.86 mg/mL; 109.46 mM
